What is Novavax's finance lease, principal payments?

Novavax (NVAX) reported finance lease, principal payments of $578K in Q1 2026.

How has Novavax's finance lease, principal payments changed year-over-year?

Novavax's finance lease, principal payments decreased by 73.7% year-over-year, from $2.2M to $578K.

What is the long-term trend for Novavax's finance lease, principal payments?

Over 4 years (2021 to 2025), Novavax's finance lease, principal payments has grown at a -47.0% compound annual growth rate (CAGR), from $127.91M to $10.07M.

Novavax NVAX Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Roivant SciencesROIV

——

ImmunityBio, Inc.IBRX

——

BioCryst PharmaceuticalsBCRX

——

LQD

Liquidia CorporationLQDA

——

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's finance lease, principal payments?: Novavax (NVAX) reported finance lease, principal payments of $578K in Q1 2026.
How has Novavax's finance lease, principal payments changed year-over-year?: Novavax's finance lease, principal payments decreased by 73.7% year-over-year, from $2.2M to $578K.
What is the long-term trend for Novavax's finance lease, principal payments?: Over 4 years (2021 to 2025), Novavax's finance lease, principal payments has grown at a -47.0% compound annual growth rate (CAGR), from $127.91M to $10.07M.